Trial Profile
Study to effectively monitor dabigatran treatment in real life atrial fibrillation patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Stroke; Thrombosis
- Focus Pharmacokinetics
- 06 Dec 2015 New trial record